Summary
The Supreme Court of Kentucky affirmed a judgment in a products-liability and medical-malpractice case involving the drug Parlodel and the death of Mary Gunderson from an alleged Parlodel-induced postpartum seizure. The court held that the trial court adequately evaluated the reliability and relevance of the plaintiffs’ causation experts under Daubert without a formal hearing or express written findings. It also concluded that the causation evidence was sufficient for jury consideration and that the admission of evidence concerning a cross-claim, though erroneous, was harmless.
Holdings
- A formal Daubert hearing is not required when the trial court has a sufficiently complete record to evaluate the proposed expert testimony for reliability and relevance. The trial court did not abuse its discretion because it reviewed extensive expert materials and conducted substantial argument concerning the underlying scientific evidence.
- A trial court need not recite each Daubert factor or issue detailed express findings of fact if the record demonstrates that the court conducted an effective reliability inquiry. The absence of express findings alone is not grounds for reversal.
- Under Daubert, a causation expert may rely on an aggregate body of scientifically grounded evidence, including case reports, adverse-drug-reaction reports, animal studies, chemical analogies, medical literature, and epidemiological evidence, even when no single item conclusively establishes causation and no epidemiological study is available. The evidence here was sufficiently reliable and relevant to be submitted to the jury.
- The Gundersons presented sufficient reliable and relevant evidence for the jury to find that Parlodel can cause postpartum seizures and that Mary Gunderson died from a Parlodel-induced seizure. The trial court properly denied the directed-verdict motion.
- Although Kentucky recognizes the learned-intermediary doctrine, the trial court did not err by refusing Sandoz's proposed instruction because Sandoz failed to present sufficient evidence that it adequately warned Dr. Armstrong of Parlodel's risks.
- The evidence was sufficient to submit Dr. Armstrong's medical-malpractice liability to the jury. FDA approval and the absence of a package-insert contraindication did not conclusively establish compliance with the applicable standard of care.
- Evidence of the children’s relationship with their father's girlfriend was properly excluded from the loss-of-parental-consortium claim because a parent-child relationship is unique and not replaceable by another relationship.
- Dr. Bower's testimony concerning the emotional effects of Mary Gunderson's death on her children was admissible under KRE 702 and Daubert because it was based on specialized education and experience, repeated observations and conversations, and a limited assessment rather than a definitive diagnosis.
- The trial court erred by admitting Dr. Armstrong's cross-claim to prove Sandoz's liability because a party's admission is admissible only against the declaring party and not against a coparty, and KRE 408 did not authorize use of the cross-claim as substantive liability evidence. The error was harmless and did not warrant reversal.
- Sandoz was not entitled to a directed verdict on punitive damages because sufficient evidence supported a finding of wanton or reckless disregard and a nexus between the relevant out-of-state conduct and Mary Gunderson's injury. A retrial limited to punitive damages was permissible, but the jury must be allowed to award no punitive damages and must be instructed on the permissible use of extraterritorial conduct.
Questions Presented
- Whether the trial court abused its discretion by failing to conduct a formal Daubert hearing before admitting the Gundersons' causation experts' testimony.
- Whether the trial court was required to make express findings of fact regarding its Daubert ruling.
- Whether case reports, adverse-drug-reaction reports, animal studies, chemical analogies, and related evidence were sufficiently reliable and relevant under Daubert.
- Whether the Gundersons presented sufficient reliable evidence of general and specific causation to withstand directed verdict.
- Whether the appellants preserved their challenge to limits on cross-examination of the causation experts.
- Whether the trial court erred by refusing to give Sandoz a learned-intermediary instruction.
- Whether Dr. Armstrong preserved and established his claim for an unavoidably-unsafe-drug instruction.
- Whether sufficient evidence supported the medical-malpractice claim against Dr. Armstrong.
- Whether evidence of the children’s relationship with their father’s girlfriend was admissible to mitigate loss-of-parental-consortium damages.
- Whether Dr. Bower’s testimony concerning the children’s emotional injuries was admissible under KRE 702 and Daubert.
- Whether admission of Dr. Armstrong’s cross-claim against Sandoz to prove Sandoz’s liability was erroneous and, if so, reversible.
- Whether Sandoz was entitled to a directed verdict on punitive damages and whether a retrial limited to punitive damages was permissible.
Disposition
affirmed
Cases Cited (22)
- Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993)(followed)
- Commonwealth v. Christie, 98 S.W.3d 485 (Ky. 2002)(followed)
- City of Owensboro v. Adams, 136 S.W.3d 446 (Ky. 2004)(followed)
- Miller v. Eldridge, 146 S.W.3d 909 (Ky. 2004)(followed)
- Goodyear Tire & Rubber Co. v. Thompson, 11 S.W.3d 575 (Ky. 2000)(followed)
- Rider v. Sandoz Pharm. Corp., 295 F.3d 1194 (11th Cir. 2002)(distinguished)
- Glastetter v. Novartis Pharm. Corp., 252 F.3d 986 (8th Cir. 2001)(distinguished)
- Globetti v. Sandoz Pharmaceuticals Corp., 111 F. Supp. 2d 1174 (N.D. Ala. 2000)(followed)
- Brasher v. Sandoz Pharmaceuticals Corp., 160 F. Supp. 2d 1291 (N.D. Ala. 2001)(followed)
- Kuhn v. Sandoz Pharm. Corp., 270 Kan. 443, 14 P.3d 1170 (2000)(followed)
Showing top 10 of 22.
Cited In (0)
No citing cases on record yet.